Related references
Note: Only part of the references are listed.Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
Ivan O. Rosas et al.
ECLINICALMEDICINE (2022)
Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa
Sujun Li et al.
GENE THERAPY (2021)
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Pingzheng Mo et al.
CLINICAL INFECTIOUS DISEASES (2021)
Tackling COVID-19 infection through complement-targeted immunotherapy
Sonata Jodele et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds
Cristina Bezzio et al.
GUT (2021)
Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Dong Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
Hong Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab
Bryant Yang et al.
CLINICAL INFECTIOUS DISEASES (2021)
Remdesivir against COVID-19 and Other Viral Diseases
Jakob J. Malin et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
RNA interference as a promising treatment against SARS-CoV-2
Ahmed Donia et al.
INTERNATIONAL MICROBIOLOGY (2021)
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
Benjamin S. Abella et al.
JAMA INTERNAL MEDICINE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
Piotr Eder et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors et al.
NATURE COMMUNICATIONS (2021)
Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19 A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial
Xavier Mariette et al.
JAMA INTERNAL MEDICINE (2021)
Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic
Joshua D. Brown
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2021)
Ultrasound-Guided Cytosolic Protein Delivery via Transient Fluorous Masks
Janna N. Sloand et al.
ACS NANO (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
(+)-Limonene 1,2-Epoxide-Loaded SLNs: Evaluation of Drug Release, Antioxidant Activity, and Cytotoxicity in an HaCaT Cell Line
Eliana B. Souto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
Perillaldehyde 1,2-epoxide Loaded SLN-Tailored mAb: Production, Physicochemical Characterization and In Vitro Cytotoxicity Profile in MCF-7 Cell Lines
Eliana B. Souto et al.
PHARMACEUTICS (2020)
Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
Jiajia Chen et al.
ENGINEERING (2020)
Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells
Francesca Punzo et al.
Oncotarget (2020)
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
Abinit Saha et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N. Lian et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
Cecilia T. Costiniuk et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
COVID-19 infection in Crohn's disease under treatment with adalimumab
Antonio Tursi et al.
GUT (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Uncovering the Hidden Antibiotic Potential of Cannabis
Maya A. Farha et al.
ACS INFECTIOUS DISEASES (2020)
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Francesca Rossi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Avoiding pitfalls in the pursuit of a COVID-19 vaccine
Lynne Peeples
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
Jahan S. Khalili et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients
Chiranjib Chakraborty et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Baricitinib for COVID-19: a suitable treatment?
Ennio G. Favalli et al.
LANCET INFECTIOUS DISEASES (2020)
Immunomodulation in COVID-19
Nicholas E. Ingraham et al.
LANCET RESPIRATORY MEDICINE (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Christian Leborgne et al.
NATURE MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Characteristics of Covid-19 in New York City
Parag Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
Lo'ai Alanagreh et al.
PATHOGENS (2020)
Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults
Jack M. Hobbs et al.
PHYTOTHERAPY RESEARCH (2020)
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes
Christina C. Price et al.
CHEST (2020)
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
Bakiye Goker Bagca et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Pharmaco-Immunomodulatory Therapy in COVID-19
John G. Rizk et al.
DRUGS (2020)
Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019
Megan Melody et al.
IMMUNOTHERAPY (2020)
Ribavirin therapy for severe COVID-19: a retrospective cohort study
Song Tong et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series
Iris Navarro-Millan et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
Annette Langer-Gould et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
Aldo Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
Sonu Bhaskar et al.
FRONTIERS IN IMMUNOLOGY (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
Chaofu Wang et al.
EBIOMEDICINE (2020)
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19
Mohammed M. Alvi et al.
JOURNAL OF DRUG TARGETING (2020)
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
Sai Kiran S. S. Pindiprolu et al.
MEDICAL HYPOTHESES (2020)
Are Genetic Vaccines the Right Weapon against COVID-19?
Antonella Conforti et al.
MOLECULAR THERAPY (2020)
The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
Kevin V. Morris
MOLECULAR THERAPY (2020)
Cytokine storm induced by SARS-CoV-2
Peipei Song et al.
CLINICA CHIMICA ACTA (2020)
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)
Calvin C. Sheng et al.
CLINICAL CARDIOLOGY (2020)
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment
Swamy Yeleswaram et al.
CLINICAL IMMUNOLOGY (2020)
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Kevin Mayer
Genetic Engineering & Biotechnology News (2020)
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial
Keisha Smith et al.
TRIALS (2020)
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
Chuang Guo et al.
NATURE COMMUNICATIONS (2020)
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Pierre-Francois Dequin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter W. Horby et al.
LANCET (2020)
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H. M. Furtado et al.
LANCET (2020)
Covid-19: Experts advise cautious optimism for neutralising antibodies after early results
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
Massimo Caracciolo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Xinfu Zhang et al.
SCIENCE ADVANCES (2020)
Cannabinoids and the Coronavirus
Kevin P. Hill
CANNABIS AND CANNABINOID RESEARCH (2020)
Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
M. Hunter Land et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Nucleic acid-based therapy for coronavirus disease 2019
Ravikant Piyush et al.
HELIYON (2020)
Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA
Hesam Khodadadi et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
Anindya Samanta et al.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Immune Responses Regulated by Cannabidiol
James M. Nichols et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Zikuan Leng et al.
AGING AND DISEASE (2020)
Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells
Eliana B. Souto et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
Ji Liu et al.
ADVANCED MATERIALS (2019)
Cannabis and Cannabinoids: Kinetics and Interactions
Brian C. Foster et al.
AMERICAN JOURNAL OF MEDICINE (2019)
A systematic review of cannabidiol dosing in clinical populations
S. A. Millar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Chelsea Kotch et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis
Aleksandra Zielinska et al.
MOLECULES (2019)
Key production parameters for the development of solid lipid nanoparticles by high shear homogenization
Eliana B. Souto et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2019)
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Allison M. Keeler et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Margaret A. Liu
VACCINES (2019)
The Clinical Trials of Mesenchymal Stem Cell Therapy in Skin Diseases: An Update and Concise Review
Ali Golchin et al.
CURRENT STEM CELL RESEARCH & THERAPY (2019)
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
Guojun Chen et al.
NATURE NANOTECHNOLOGY (2019)
Macrophage PPAR-γ suppresses long-term lung fibrotic sequelae following acute influenza infection
Su Huang et al.
PLOS ONE (2019)
High-potency ligands for DREADD imaging and activation in rodents and monkeys
Jordi Bonaventura et al.
NATURE COMMUNICATIONS (2019)
Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors
Dareen A. Youssef et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
Francieli Vuolo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine
Lijun Chen et al.
STEM CELL RESEARCH & THERAPY (2019)
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
Cecilia T. Costiniuk et al.
BMJ OPEN (2019)
Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice
Alireza Tahamtan et al.
VIRULENCE (2018)
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
Molly Braun et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
Monica Casucci et al.
FRONTIERS IN IMMUNOLOGY (2018)
Nucleic Acid-Based Therapeutics for Pulmonary Diseases
Jing Chen et al.
AAPS PHARMSCITECH (2018)
Cannabinoid 2 receptor attenuates inflammation during skin wound healing by inhibiting M1 macrophages rather than activating M2 macrophages
Yu Du et al.
JOURNAL OF INFLAMMATION-LONDON (2018)
Enteric coatings for colonic drug delivery: state of the art
Alessandra Maroni et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
Rudragouda Channappanavar et al.
JOURNAL OF IMMUNOLOGY (2017)
Immunoregulatory Role of Cannabinoids during Infectious Disease
Rosalia Hernandez-Cervantes et al.
NEUROIMMUNOMODULATION (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency
Nadia Starc et al.
SCIENTIFIC REPORTS (2017)
Tocilizumab: A Review in Rheumatoid Arthritis
Lesley J. Scott
DRUGS (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Potential of Cannabidiol for the Treatment of Viral Hepatitis
Henry I. C. Lowe et al.
PHARMACOGNOSY RESEARCH (2017)
Formulation and development of orodispersible sustained release tablet of domperidone
Hemlata G. Patil et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2016)
Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors
Jackye Peretz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Electroporation and lipid nanoparticles with cyanine IR-780 and flavonoids as efficient vectors to enhanced drug delivery in colon cancer
Julita Kulbacka et al.
BIOELECTROCHEMISTRY (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation
Slavomira Doktorovova et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Cannabidiol: a potential treatment for post Ebola syndrome?
Sandra E. Reznik et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)
Luka Dobovisek et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
Oier Aizpurua-Olaizola et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Macrophages: A review of their role in wound healing and their therapeutic use
Robert J. Snyder et al.
WOUND REPAIR AND REGENERATION (2016)
Mesenchymal stem cells and immunomodulation: current status and future prospects
F. Gao et al.
CELL DEATH & DISEASE (2016)
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
Lirit N. Franks et al.
FRONTIERS IN PHARMACOLOGY (2016)
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Arthur Kavanaugh
Therapeutics and Clinical Risk Management (2016)
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
X. Roblin et al.
JOURNAL OF CROHNS & COLITIS (2015)
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells
Lei Yang et al.
MEDIATORS OF INFLAMMATION (2015)
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury
A. Ribeiro et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2015)
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
Robert F. Foronjy et al.
BMC IMMUNOLOGY (2014)
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - A systematic review of in vitro data
[Anonymous]
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
J. Sardinha et al.
MEDIATORS OF INFLAMMATION (2014)
An update on feline infectious peritonitis: Virology and immunopathogenesis
Niels C. Pedersen
VETERINARY JOURNAL (2014)
Advances in nanomedicines for malaria treatment
N. P. Aditya et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2013)
Identification of raloxifene as a novel CB2 inverse agonist
Pritesh Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles
Medha Patel et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
M. Mecha et al.
NEUROBIOLOGY OF DISEASE (2013)
A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing
J. F. Fangueiro et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2013)
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
Alison Ribeiro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway
S. Martins et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication
Dae-Gyun Ahn et al.
ANTIVIRAL RESEARCH (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
Waqqas Afif et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Josep Bassaganya-Riera et al.
VIRAL IMMUNOLOGY (2010)
Improving Oral Absorption of Samon Calcitonin by Trimyristin Lipid Nanoparticles
S. Martins et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2009)
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
Mark L. Brantly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome
Houli Wang et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2008)
A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells
Cheryl E. Rockwell et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Nanostructured lipid carrier (NLC) based gel of celecoxib
Medha Joshi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine
Kamalinder K. Singh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®)
E. B. Souto et al.
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (2008)
Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery:: Structure, protection and skin effects
E. B. Souto et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2007)
Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) -: Effects of formulation parameters on physicochemical stability
Veerawat Teeranachaideekul et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Solid lipid nanoparticles as a drug delivery system for peptides and proteins
Antonio J. Almeida et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
Thomas W. Klein et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Antisense downregutation of SARS-CoV gene expression in Vero E6 cells
Y Shi et al.
JOURNAL OF GENE MEDICINE (2005)
Inhibition of SARS-CoV replication by siRNA
CJ Wu et al.
ANTIVIRAL RESEARCH (2005)
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
CJ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
EB Souto et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
ACE2: from vasopeptidase to SARS virus receptor
AJ Turner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids
YH Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Share Paper
